Find Therapeutics is a private biopharmaceutical company based in Montreal, Canada. The company specialized in designing peptide-based treatment by precision-targeting intramembrane receptors. Its lead asset are being developed for the treatment of demyelinating disease like neuromyelitis optica or multiple sclerosis.
Demyelinating diseases
CTI LSF II
Lead
Director & Observer
June 7, 2020
n/a
Seed
Find Therapeutics' platform that could design differentiated peptide-based therapies for intramembrane targets and its lead asset showed promising pre-clinical data
